Literature DB >> 30887884

Exploration of interaction mechanism of tyrosol as a potent anti-inflammatory agent.

Tara Chand Yadav1, Naresh Kumar2, Utkarsh Raj3, Nidhi Goel4, Pritish Kumar Vardawaj3, Ramasare Prasad1, Vikas Pruthi1.   

Abstract

Drug discovery for a vigorous and feasible lead candidate is a challenging scientific mission as it requires expertise, experience, and huge investment. Natural products and their derivatives having structural diversity are renowned source of therapeutic agents since many years. Tyrosol (a natural phenylethanoid) has been extracted from olive oil, and its structure was confirmed by elemental analysis, FT-IR, FT-NMR, and single crystal X-ray crystallography. The conformational analysis for tyrosol geometry was performed by Gaussian 09 in terms of density functional theory. Validation of bond lengths and bond angles obtained experimentally as well as theoretically were performed with the help of curve fitting analysis, and values of correlation coefficient (R) obtained as 0.988 and 0.984, respectively. The charge transfer within the tyrosol molecule was confirmed by analysis of HOMO→LUMO molecular orbitals. In molecular docking with COX-2 (PDB ID: 5F1A), tyrosol was found to possess satisfactory binding affinity as compared to other NSAIDs (Aspirin, Ibuprofen, and Naproxen) and a COX-2 selective drug (Celecoxib). ADMET prediction, drug-likeness and bioactivity score altogether confirm the lead/drug like potential of tyrosol. Further investigation of simulation quality plot, RMSD and RMSF plots, ligands behavior plot as well as post simulation analysis manifest the consistency of 5F1A-tyrosol complex throughout the 20 ns molecular simulation process that signifies its compactness and stability within the receptor pocket. AbbreviationsADMETAbsorption, Distribution, Metabolism, Excretion and ToxicityÅAngstromCOX-2Cyclooxygenase-2DFTDensity Functional TheoryDMFDimethylformamideFMOFrontier Molecular OrbitalFT-IRFourier-transform Infrared SpectroscopyFT-NMRNuclear Magnetic Resonance SpectroscopyHOMOHighest Occupied Molecular OrbitalLUMOLowest Unoccupied Molecular OrbitalMDMolecular DynamicsNSNanosecondNSAIDsNon-steroidal anti-inflammatory drugsOPEOsiris Property ExplorerRMSDRoot-Mean-Square DeviationRMSFRoot Sean Square FluctuationCommunicated by Ramaswamy H. Sarma.

Entities:  

Keywords:  ADMET; COX-2; Tyrosol; ab initio; molecular docking; molecular dynamics simulation

Mesh:

Substances:

Year:  2019        PMID: 30887884     DOI: 10.1080/07391102.2019.1575283

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  5 in total

Review 1.  Is Extra Virgin Olive Oil an Ally for Women's and Men's Cardiovascular Health?

Authors:  Flavia Franconi; Ilaria Campesi; Annalisa Romani
Journal:  Cardiovasc Ther       Date:  2020-04-24       Impact factor: 3.023

2.  Mollusc-Derived Brominated Indoles for the Selective Inhibition of Cyclooxygenase: A Computational Expedition.

Authors:  Md Mominur Rahman; Md Junaid; S M Zahid Hosen; Mohammad Mostafa; Lei Liu; Kirsten Benkendorff
Journal:  Molecules       Date:  2021-10-29       Impact factor: 4.411

Review 3.  Extra Virgin Olive Oil (EVOO), a Mediterranean Diet Component, in the Management of Muscle Mass and Function Preservation.

Authors:  Sara Salucci; Anna Bartoletti-Stella; Alberto Bavelloni; Beatrice Aramini; William L Blalock; Francesco Fabbri; Ivan Vannini; Vittorio Sambri; Franco Stella; Irene Faenza
Journal:  Nutrients       Date:  2022-08-30       Impact factor: 6.706

4.  Isolation and Characterization of an Endophytic Fungus Colletotrichum coccodes Producing Tyrosol From Houttuynia cordata Thunb. Using ITS2 RNA Secondary Structure and Molecular Docking Study.

Authors:  Rajreepa Talukdar; Srichandan Padhi; Amit K Rai; Marco Masi; Antonio Evidente; Dhruva Kumar Jha; Alessio Cimmino; Kumananda Tayung
Journal:  Front Bioeng Biotechnol       Date:  2021-06-17

Review 5.  Anti-Inflammatory and Restorative Effects of Olives in Topical Application.

Authors:  Mahdiyeh Taheri; Leila Amiri-Farahani
Journal:  Dermatol Res Pract       Date:  2021-06-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.